The significance of neuronal lateralisation in Parkinson's disease

Journal of Neural Transmission

Volumn 119, Issue 8, 2012, Pages 953-962

  Riederer, P ^a   Sian Hulsmann J ^a,b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Developmental disorder; Lateralisation; Parkinson's disease

Indexed keywords

BRAIN ASYMMETRY; BRAIN FUNCTION; COGNITION; DENERVATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; GENETIC DISORDER; HEMISPHERE; HUMAN; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUBSTANTIA NIGRA;

DOMINANCE, CEREBRAL; HUMANS; NEURONS; PARKINSON DISEASE;

EID: 84865130684     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0775-1     Document Type: Review

References (111)

1. Abbas N, Lucking CB, Human RS (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Mol Genetics 8:567-574 (Pubitemid 29139969)
2. Androulidakis AG, Kühn AA, Chen CC, Blomstedt P, Kempf F, Kupsch A, Schneider GH, Doyle L, Dowsey-Limousin P, Hariz MI, Brown P (2007) Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease. Brain. 130(2):457-468 (Pubitemid 46181099)
3. Antony PM, Diederich NJ, Balling R (2011) Parkinson's disease mouse models in translational research. Mamm Genome 22(7-8):401-419
4. Ashkan K, Wallace BA, Mitrofanis J, Pollo C, Brard PY, Fagret D, Benabid AL (2007) SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease. Parkinsonism Relat Disord 13(5):266-275 (Pubitemid 47002326)
5. Avila I, Parr-Brownlie LC, Brazhnik E, Castañeda E, Bergstrom DA, Walters JR (2010) Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp Neurol 221(2):307-319
6. Baluchnejadmojarad T, Roghani M (2004) Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test. Physiol Behav 82(2-3):369-373 (Pubitemid 38981623)
7. Barber-Singh J, Seo BB, Matsuno-Yagi A, Yagi T (2010) Protective role of rAAV-NDI1, serotype 5, in an acute MPTP mouse Parkinson's model. Parkinsons Dis 2011:438370
8. Barolin GS, Bernheimer H, Hornykiewicz O (1964) Seitenverschiedenes Verhalten des Dopamins (3-Hydroxytyramin) im Gehirn eines Falles von Hemiparkinsonismus. Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie 94(2):241-248
9. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334:71-76 (Pubitemid 26017932)
10. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology S3:1026-1031 (Pubitemid 29442119)
11. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
12. Birkmayer W, Hornykiewicz O (1961) Der l-3,4-Dioxyphenylalanin (= DOPA)-Effekt bei der Parkinson-Akinese. Wr. klin. Wschr. 73:787-788
13. Birkmayer W, Mentasti M (1967) Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes). Arch Psychiatr Nervenkr. 210(1):29-35
14. Blonder LX, Gur RE, Gur RC, Saykin AJ, Hurtig HI (1989) Neuropsychological functioning in hemiparkinsonism. Brain Cogn 9:244-257
15. Bortolozzi A, Duffard R, de Duffard AM (2003) Asymmetrical development of the monoamine systems in 2,4-dichlorophenoxyacetic acid treated rats. Neurotoxicology. 24(1):149-157 (Pubitemid 36091168)
16. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 Suppl 3:III/1-5
17. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536 (Pubitemid 36543283)
18. Breit S, Martin A, Lessmann L, Cerkez D, Gasser T, Schulz JB (2008) Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model. J Neurosci Res 86(6):1388-1396 (Pubitemid 351571913)
19. Brooks DJ, Pavese N (2009) Recent imaging advances in the diagnosis and management of Parkinson's disease. F1000 Med Rep 1:82
20. Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I (2000) SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol 247 Suppl 4:IV/2-IV/7
21. Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 64(5):485-491
22. Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J (2009) NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. J Neurosci Res 87(10):2308-2318
23. Cardoso F (2002) HIV-related movement disorders; epidemiology, pathogenesis and management. CNS drugs 16(10):663-668 (Pubitemid 35176852)
24. Castellano MA, Rodriguez Diaz M (1991) Nigrostriatal dopaminergic cell activity is under control by substantia nigra of the contralateral brain side: electrophysiological evidence. Brain Res Bull 27(2):213-218
25. Castellano MA, Diaz-Palarea MD, Rodriguez M, Barroso J (1987) Lateralization in male rats and dopaminergic system: evidence of right-side population bias. Physiol Behav 40(5):607-612 (Pubitemid 17150955)
26. Castellano MA, Diaz-Palarea MD, Barroso J, Rodriguez M (1989) Behavioral lateralization in rats and dopaminergic system: individual and population laterality. Behav Neurosci 103(1):46-53 (Pubitemid 19058643)
27. 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry 76:1204-1210 (Pubitemid 41208369)
28. Choe BY, Park JW, Lee KS, Son BC, Kim MC, Kim BS, Suh TS, Lee HK, Shinn KS (1998) Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Invest Radiol 33(8):450-455 (Pubitemid 30253674)
29. Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR Jr, Kordower JH (2005) Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp Neurol 191(Suppl 1):S60-S67 (Pubitemid 40075411)
30. Colosimo C, Martínez-Martín P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG (2010) Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. Movement Disord 25(9):1131-1142
31. Cookson MR, Bandmann O (2010) Parkinson's disease: insights from pathways. Hum Mol Genet 19(R1):R21-R27
32. Cooper CA, Mikos AE, Wood MF, Kirsch-Darrow L, Jacobson CE, Okun MS, Rodriguez RL, Bowers D, Fernandez HH (2009) Does laterality of motor impairment tell us something about cognition in Parkinson disease? Parkinsonism Relat Disorder 15(4):315-317
33. Cronin-Golomb A (2010) Parkinson's disease as a disconnection syndrome. Neuropsychol Rev 20(2):191-208
34. Cubo E, Martín PM, Martin-Gonzalez JA, Rodríguez- Blázquez C, Kulisevsky J; ELEP Group Members (2010) Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord 25(1):70-75
35. Da Cunha C, Wietzikoski EC, Ferro MM, Martinez GR, Vital MA, Hipólide D, Tufik S, Canteras NS (2008) Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission. Behav Brain Res 189(2):364-372
36. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, Neville BG, Giovannoni G (2004) Encephalitits lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 127(Pt 1):21-33 (Pubitemid 38055343)
37. De La Fuente-Fernandez R (2000) Maternal effect on Parkinson's disease. Ann Neurol 48:782-787
38. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1992) Indices of oxidative stress in individuals with incidental Lewy body disease. Ann Neurol 35:38-44 (Pubitemid 24027604)
39. Ding F, Luan L, Ai Y, Walton A, Gerhardt GA, Gash DM, Grondin R, Zhang Z (2008) Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys. Exp Neurol 212(2):431-439
40. Eggers C, Schmidt A, Hagenah J, Brüggemann N, Klein JC, Tadic V, Kertelge L, Kasten M, Binkofski F, Siebner H, Neumaier B, Fink GR, Hilker R, Klein C (2010) Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology. 74(22):1798-1805
41. Espay AJ, Henderson KK (2011) Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection. Neurology 26(17):1529-1530
42. Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis A-C, Wagener A, Scheuerpflug P, Reiners K, Riederer P (2003) Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 110:1437-1443 (Pubitemid 38041348)
43. Gasparoli E, Delibori D, Polesello G, Santelli L, Ermani M, Battistin L, Bracco F (2002) Clinical predictors in Parkinson's disease. Neurol Sci 23(Suppl. 2):S77-S78 (Pubitemid 35355785)
44. Gerlach M., Reichmann H., Riederer P (2007) Die Parkinson-Krankheit. Grundlagen, Klinik, Therapie. 4. Auflage. Springer, Wien
45. Giardino L (1996) Right-left asymmetry of D-1 and D-2 receptor density is lost in the basal ganglia of old rats. Brain Res 720:235-238 (Pubitemid 26179831)
46. González-Hernández T, Barroso-Chinea P, Rodríguez M (2004) Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat. Mov Disord 19(9):1029-1042 (Pubitemid 39302835)
47. Grealish S, Mattsson B, Draxler P, Björklund A (2010) Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxy-dopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci 31:2266-2278
48. Greffard S, Verny M, Bonnet AM, Seilheart D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal dead. Neurobiol Aging 31(1):99-103
49. Grünblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MBH (2004) Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111:1543-1573 (Pubitemid 40068786)
50. Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 115:409-415
51. Hanakawa T, Katsumi Y, Fukuyama H, Honda M, Hayashi T, Kimura J, Shibasaki H (1999) Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain. 122(Pt 7):1271-1282 (Pubitemid 29324848)
52. Heim C, Sova L, Kurz T, Kolasiewicz W, Schwegler H, Sontag KH (2002) Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area - model of the early beginning of Parkinson's symptomatology? J Neural Transm. 109(5-6):691-709 (Pubitemid 34810767)
53. Henderson JM, Stanic D, Tomas D, Patch J, Horne MK, Bourke D, Finkelstein DI (2005) Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys. Behav Brain Res 160(2):267-276 (Pubitemid 40603523)
54. Hershey T, Wu J, Weaver PM, Perantie DC, Karimi M, Tabbal SD, Perlmutter JS (2008) Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol 210(2):402-408
55. Hoehn MM, Yahr MD (2001) Parkinsonism: onset, progression, and mortality. 1967. Neurology 57(10 Suppl 3):S11-S26
56. Huber SJ, Miller H, Bohaska L, Christy JA, Bornstein RA (1992) Asymmetrical cognitive differences associated with hemiparkinsonism. Arch Clin Neuropsychol 7:471-480
57. Iancu R, Mohapel P, Brundin P, Paul G (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162(1):1-10 (Pubitemid 40726275)
58. Jellinger KA (2009) Formation and development of Lewy pathology: a critical update. J Neurol 256(Suppl 3):270-279
59. Jeon MY, Lee WY, Kang HY, Chung EJ (2007) The effects of l-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models. Neurol Res 29(3):289-295 (Pubitemid 46802367)
60. Jung KY, Chung CS, Park KW (2007) Bilateral medial temporal lesions in Japanese encephalitis. Neurology. 68(16):1319 (Pubitemid 46625981)
61. Kalita J, Misra UK (2000) The substantia nigra is involved in Japanese Encephalitis. Am J Neuroradiol 21(10):1978-1980
62. Katzen H, Bonnie E, Levin B, William W (2006) Side and type of motor symptom influence cognition in Parkinson's disease. Mov Dis 21(11):1947-1953 (Pubitemid 44848943)
63. Kopin IJ (1987) MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease. Environ Health Perspect 75:45-51 (Pubitemid 18061022)
64. Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC (2004) Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. Brain Res 1016(2):170-181 (Pubitemid 38887700)
65. Lees AJ (2009) The Parkinson chimera. Neurology 72(7):S2-S11
66. Leh SE, Petrides M, Strafella AP (2010) The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology 35(1):70-85
67. Lewald J, Schirm SN, Schwarz M (2004) Sound lateralization in Parkinson's disease. Brain Res Cogn Brain Res. 21(3):335-341 (Pubitemid 39423635)
68. Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM, Fraix V, Broussolle E, Horstink MW, Vidailhet M, Verpillat P, Gasser T, Nicholl D, Teive H, Raskin S, Rascol O, Destée A, Ruberg M, Gasparini F, Meco G, Agid Y, Durr A, Brice A; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease (2003) How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 54(2):176-185 (Pubitemid 36913573)
69. Loius ED, Tang MJ, Cote L, Alfaro B, Mejia MA, Marder K (1999) Progression of parkinsonian signs in Parkinson disease. Arch Neurol 56:334-337 (Pubitemid 29120231)
70. Lücking CB, Dürr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y, Brice A; European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetic Study Group (2000) Association between early onset parkinson's disease and mutations in the PARKIN Gene. N Engl J Med 342(21):1560-1567 (Pubitemid 30340501)
71. Marti-Masso JF, Ruiz-Martinez J, Bolano MJ, Ruiz I, Gorostidi A, Moreno F, Ferrer I, Lopez de Munain A (2009) Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Mov Disord 24(13):1998-2001
72. Martinez AJ, Utterback RA (1973) Unilateral Parkinson's disease, clinical and neuropathologic findings. A case report. Neurology 23:164-170
73. Mattay VS, Tessitore A, Callicott JH, Bertolino A et al (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51:156-164 (Pubitemid 34111437)
74. Mattock C, Marmot M, Stern G (1988) Could Parkinson's disease follow intra-uterine influenza? A speculative hypothesis. J Neurol Neurosurg Psychiatry 51(6):753-756
75. McNamara P, Stavitsky K, Harris E, Szent-Imrey O, Durso R (2010) Mood, side of motor symptom onset and pain complaints in Parkinson's disease. Int J Geriatr Psychiatry. 25(5):519-524
76. Metz GA, Piecharka DM, Kleim JA, Whishaw IQ (2004) Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease. Brain Res 1026(1):126-135 (Pubitemid 39336423)
77. Nakagawa M, Ohgoh M, Nishizawa Y, Ogura H (2004) Dopaminergic agonists and muscarinic antagonists improve lateralization in hemiparkinsonian rats in a novel exploratory Y-maze. J Pharmacol Exp Ther 309(2):737-744 (Pubitemid 38542630)
78. Natsopoulos D, Katsarou Z, Alevriadou A, Grouios G, Bostantzopoulou S, Mentenopoulos G (1997) Deductive and inductive reasoning in Parkinson's disease patients and normal controls: review and experimental evidence. Cortex 33(3):463-481 (Pubitemid 27460493)
79. Nikkhah G, Falkenstein G, Rosenthal C (2001) Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance. J Neurosci 21(16):6252-6263 (Pubitemid 32737756)
80. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31(7):763-780
81. Pearson RCA, Neal JW, Powell TPS (1987) Bilateral morphological changes in the substantia nigra of the rat following unilateral damage of the striatum. Brain Res 400:127-132 (Pubitemid 17212591)
82. Picard F, de Saint-Martin A, Salmon E, Hirsch E, Marescaux C (1996) Postencephalitic stereotyped involuntary movements responsive to l-dopa. Mov Disord 11(5):567-570 (Pubitemid 26306084)
83. Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ (1999) The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45(5):577-582 (Pubitemid 29217585)
84. Polak T, Ehlis AC, Langer J, Plichta M, Metzger F, Ringel TM, Fallgatter AJ (2007) Non-invasive measurement of vagus activity diagnosis of dementias? J Neural Transm 114:613-619 (Pubitemid 46664057)
85. Polak T, Weise D, Metzger F, Ehlis AC, Langer JB, Schramm A, Fallgatter AJ, Classen J (2011) Vagus nerve somatosensory evoked potentials in Parkinson's disease. J Neurol 258:2276-2277
86. Przuntek H, Müller T, Riederer P (2004) Diagnostic staging of Parkinson's disease: conceptual aspects. J Neural Transm 111:201-216 (Pubitemid 38283231)
87. Riederer P, Foley P (2002) Mini-review: multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism. J Neural Transm. 109(12):1469-1475 (Pubitemid 36057056)
88. Riederer P, Wuketich S (1976) Time course of nigrostriatal degeneration in Parkinson's disease. J Neural Transm 38:277-301
89. Riederer P, Sofic E, Rausch WD, Schmid B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520 (Pubitemid 19037617)
90. Riederer P, Foley P, Bringmann G, Feineis D, Brückner R, Gerlach M (2002) Biochemical and pharmacological characterization of 1-trichloromethyl-1, 2,3,4-tetrahydro-βcarboline: a biologically relevant neurotoxin? European J Pharmacology 442:1-16 (Pubitemid 34521841)
91. Riklan M, Stellar S, Reynolds C (1990) The relationship of memory and cognition in Parkinson's disease to lateralisation of motor symptoms. J Neurol Neurosurg Psychiatry 53:359-360 (Pubitemid 20152026)
92. Rinne JO, Laihinen A, Rinne UK, Någren K, Bergman J, Ruotsalainen U (1993) PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease. Mov Disord 8:134-138 (Pubitemid 23131632)
93. Rissanen E, Paavilainen T, Virta J, Marttila RJ, Rinne JO, Airas L (2010) Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET). Neurotoxicology. 31(4):403-407
94. Rosvold HE, Delgado JMR (1956) The effect on delayed-alternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey's brain. J Comp Physiol Psychol 49:365-372
95. Schendan HE, Amick MM, Cronin-Golomb A (2009) Role of a lateralized parietal-basal ganglia circuit in hierarchical pattern perception: evidence from Parkinson's disease. Behav Neurosci 123(1):125-136
96. Schneider LH, Murphy RB, Coons EE (1982) Lateralization of striatal dopamine (D2) receptors in normal rats. Neurosci Lett 33(3):281-284 (Pubitemid 13119534)
97. Shen YQ, Hebert G, Su Y, Moze E, Neveu PJ, Li KS (2005) In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization. Brain Res 1045(1-2):31-37 (Pubitemid 40725217)
98. Shinotoh H, Uchida Y, Hisao I, Hattori T (2000) Relationship between striatal [123I]beta-CIT binding and four major clinical signs in Parkinson's disease. Ann Nucl Med 14:199-203 (Pubitemid 30485355)
99. Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem 118(6):939-957
100. Tang CC, Poston KL, Dhawan V, Eidelberg D (2010) Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 30(3):1049-1056
101. Tomer R, Levin BE, Weiner WJ (1993) Side of onset of motor symptoms influences cognition in Parkinson's disease. Ann Neurol 34:579-584 (Pubitemid 23289410)
102. Van Camp N, Vreys R, Van Laere K, Lauwers E, Beque D, Verhoye M, Casteels C, Verbruggen A, Debyser Z, Mortelmans L, Sijbers J, Nuyts J, Baekelandt V, Van der Linden A (2010) Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI. MAGMA. 23(2):65-75
103. Van der Hoorn A, Bartels AL, Leenders KL, Jong BM (2011) Handedness and dominant side symptoms in Parkinson's disease. Parkinsonism Relat Disord 17:58-60
104. Wang SJ, Liu RS, Liu HC, Lin KN, Shan DE, Liao KK, Fuh JL, Lee LS (1993) Technetium-99m hexamethyl amine oxime single PET tomography of the brain in early Parkinson's disease: correlation with dementia and lateralisation. Eur. J. Nucl 20(4):339-344
105. Wang H, Katz J, Dagostino P, Soghomonian JJ (2007) Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata. Neuroscience. 145(2):727-737 (Pubitemid 46341648)
106. Wang S, Zhang QJ, Liu J, Wu ZH, Wang T, Gui ZH, Chen L, Wang Y (2009) Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Neuroscience. 159(2):850-861
107. Wichmann T, DeLong MR (1998) Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg Clin North Am 9:223-236 (Pubitemid 28169298)
108. Wright WG, Gurfinkel V, King L, Horak F (2007) Parkinson's disease shows perceptuomotor asymmetry unrelated to motor symptoms. Neurosci Lett 417(1):10-15 (Pubitemid 46517835)
109. Wu RM, Shan DE, Sun CM, Liu RS, Hwu WL, Tai CH, Hussey J, West A, Gwinn-Hardy K, Hardy J, Chen J, Farrer M, Lincoln S (2002) Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. Mov Disord 17(4):670-675 (Pubitemid 41295005)
110. Xu ZC, Ling G, Sahr RN, Neal-Beliveau BS (2005) Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion. Brain Res 1038(2):163-170 (Pubitemid 40332681)
111. Xu X, Wang Q, Zhang M (2008) Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage. 40(1):35-42